Moscow has signed the first agreement within the new city program aimed at stimulating the job creation. The project investor will construct a 46,000-square-meter complex of office buildings Ostankino Business Park in the Butyrsky subdistrict by the end of 2023, which can potentially give the city 4,000+ new jobs.

RELATED MATERIALS

In more detail
28 Oct
Number of Premises Sold at City E-Auctions More Than Doubled in Seven Years
In more detail
27 Oct
New Simplified Scheme for Placing Non-Permanent Sports Facilities
In more detail
23 Oct
Moscow Non-Resource Non-Energy Export Grew Almost by 30%
Speech at the Plenary Meeting of the III Moscow Urban Forum
Merck
Merck Company does not need to be introduced: more than three centuries of presence at the global health care market, life science and high-tech materials developing speak for themselves. CEO of Merck Life Science in Russia and the CIS Heinz Schmidt told in an interview to investmoscow.ru about the company's mission in our country and innovation laboratory work in the capital.
Moscow Pharmaceutical Factory
The history of the Moscow Pharmaceutical Factory began in the 1930s. Moscow had a fast-growing demand for medications and pharmacies were cropping up. Mostly, factories produced “galenic” medications (tinctures, extracts, and drops based thereon) derived from medicinal plants: motherwort, valerian root, calendula, eleuthero, etc.
All topics